| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An evaluation of the interaction of pixantrone with formaldehyde-releasing drugs in cancer cells
|
Mansour, Oula C.
|
|
|
89 |
6 |
p. 773-784
|
article
|
| 2 |
A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma
|
Liu, Weiping
|
|
|
89 |
6 |
p. 825-831
|
article
|
| 3 |
Comparison of docetaxel pharmacokinetics between castration-resistant and hormone-sensitive metastatic prostate cancer patients
|
Vermunt, Marit A. C.
|
|
|
89 |
6 |
p. 785-793
|
article
|
| 4 |
Correction to: Evaluation of the absolute oral bioavailability of the anaplastic lymphoma kinase/c-ROS oncogene 1 kinase inhibitor lorlatinib in healthy participants
|
Hibma, Jennifer E.
|
|
|
89 |
6 |
p. 839
|
article
|
| 5 |
Dose-dependent bioavailability, absorption-rate limited elimination, and tissue distribution of the ATR inhibitor BAY-1895344 (elimusertib) in mice
|
Kiesel, Brian F.
|
|
|
89 |
6 |
p. 795-807
|
article
|
| 6 |
Editorial Expression of Concern for: Induction of apoptosis by [6]-gingerol associated with the modulation of p53 and involvement of mitochondrial signaling pathway in B[a]P-induced mouse skin tumorigenesis
|
Nigam, Nidhi
|
|
|
89 |
6 |
p. 841
|
article
|
| 7 |
Elimination of tucatinib, a small molecule kinase inhibitor of HER2, is primarily governed by CYP2C8 enantioselective oxidation of gem-dimethyl
|
Sun, Hao
|
|
|
89 |
6 |
p. 737-750
|
article
|
| 8 |
Feasibility of therapeutic drug monitoring of sunitinib and its implications on response and toxicity in patients with metastatic renal cell cancer
|
Gandhi, Khushboo A.
|
|
|
89 |
6 |
p. 751-759
|
article
|
| 9 |
RETRACTED ARTICLE: Effectiveness and safety of sorafenib for renal cell, hepatocellular and thyroid carcinoma: pooled analysis in patients with renal impairment
|
Oya, Mototsugu
|
|
|
89 |
6 |
p. 761-772
|
article
|
| 10 |
Retraction Note to: MicroRNA‑30c‑regulated HDAC9 mediates chemoresistance of breast cancer
|
Liang, Zhongxing
|
|
|
89 |
6 |
p. 843
|
article
|
| 11 |
Risk factors of proteinuria and potentially protective effect of renin–angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib
|
Ikesue, Hiroaki
|
|
|
89 |
6 |
p. 833-838
|
article
|
| 12 |
The effects of two gold-N-heterocyclic carbene (NHC) complexes in ovarian cancer cells: a redox proteomic study
|
Massai, Lara
|
|
|
89 |
6 |
p. 809-823
|
article
|
Journal description